top of page

Jun 11, 2021

Centene Goes “Sci-Fi” with new Brain Treatment

Updated: Feb 28, 2022

Highlights around the partnership between BrainsWay and Centene regarding Deep TMS™ coverage, with commentary from CEO Christopher von Jako.

Health Payer Specialist Article

Recent Posts

Non-Drug, Non-Invasive, FDA-Cleared Device to Treat OCD

We Need a Clearer Understanding of Treatment-Resistant Depression, Experts Say

Transcranial Magnetic Stimulation Shows Promise for Alcohol Addiction

Commentaires

bottom of page